Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1994-06-10
1998-01-20
Fleisher, Mindy
Chemistry: molecular biology and microbiology
Spore forming or isolating process
424 932, 424 9321, 4352401, 4353201, 536 2372, 536 241, C12N 1586, C12N 1563, C12N 1548, C12N 510
Patent
active
057100373
ABSTRACT:
A retroviral vector which includes a nucleic acid sequence encoding a retroviral envelope. The nucleic acid sequence encoding a retroviral envelope includes a first nucleic acid sequence encoding a first envelope portion which is a portion of MCF viral gp 70 protein, a nucleic acid sequence which encodes xenotropic envelope, a nucleic acid sequence which encodes an amphotropic envelope portion, and a nucleic acid sequence which encodes p15E protein. Such retroviral envelopes encoded by such nucleic acid sequence may be included in infectious viral particles. The infectious viral particles also may include gene(s) encoding therapeutic agents, and thus may be used in gene therapy.
REFERENCES:
Van Beveren et al., J. Virol. 41(2):542-556 (1982).
O'Neill et al., J. Virol. 53(1):100-106 (1985).
Adachi, et al., J. Virol., vol. 50, No. 3, pp. 813-821 (Jun. 1984).
Ott, et al., J. Virol., vol. 64, No. 2, pp. 757-766 (Feb. 1990).
Donahue, et al., J. Exp. Med., vol. 176, pp. 1125-1135 (Oct. 1992).
Nienhuis Arthur W.
Vanin Elio F.
Fleisher Mindy
Lillie Raymond J.
Olstein Elliot M.
Railey II Johnny F.
The United States of America as represented by the Department of
LandOfFree
Retroviral vector particles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retroviral vector particles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral vector particles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-724733